Terms: = Gastric cancer AND LRP1B, ENSG00000168702, 53353, Q9NZR2, LRPDIT, LRP-DIT
24 results:
1. The Relationship Between Gene Mutations and the Clinicopathological Features and Prognosis of gastric cancer.
Nie Z; Zeng K; Yan Q; Liu Y; Bian Y; Zhu J; Guo Z; He F; Shi H; Guo Y
Int J Surg Pathol; 2024 May; 32(3):486-495. PubMed ID: 37545327
[TBL] [Abstract] [Full Text] [Related]
2. The tumor biological significance of RNF43 and lrp1b in gastric cancer is complex and context-dependent.
Holm B; Barsuhn S; Behrens HM; Krüger S; Röcken C
Sci Rep; 2023 Feb; 13(1):3191. PubMed ID: 36823311
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of the mutation patterns between tumor tissue and cell-free DNA in stage IV gastric cancer.
Kung CY; Fang WL; Hung YP; Huang KH; Chen MH; Chao Y; Lin SC; Li AF; Lo SS; Wu CW
Aging (Albany NY); 2023 Feb; 15(3):777-790. PubMed ID: 36779847
[TBL] [Abstract] [Full Text] [Related]
4. Integrative analysis of the proteome and transcriptome in gastric cancer identified lrp1b as a potential biomarker.
Miao J; Yang Z; Guo W; Liu L; Song P; Ding C; Guan W
Biomark Med; 2022 Oct; 16(15):1101-1111. PubMed ID: 36606427
[No Abstract] [Full Text] [Related]
5. PIK3CA somatic mutations as potential biomarker for immunotherapy in elder or TP53 mutated gastric cancer patients.
Yao J; You Q; Zhang X; Zhang Y; Xu J; Zhao X; Li J; Wang X; Gong Z; Zhang D; Wang W
Clin Genet; 2023 Feb; 103(2):200-208. PubMed ID: 36346122
[TBL] [Abstract] [Full Text] [Related]
6. Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract.
Wu H; Yu Z; Liu Y; Guo L; Teng L; Guo L; Liang L; Wang J; Gao J; Li R; Yang L; Nie X; Su D; Liang Z
Cancer Commun (Lond); 2022 Dec; 42(12):1367-1386. PubMed ID: 36264285
[TBL] [Abstract] [Full Text] [Related]
7. Characteristics of gastric cancer around the world.
López MJ; Carbajal J; Alfaro AL; Saravia LG; Zanabria D; Araujo JM; Quispe L; Zevallos A; Buleje JL; Cho CE; Sarmiento M; Pinto JA; Fajardo W
Crit Rev Oncol Hematol; 2023 Jan; 181():103841. PubMed ID: 36240980
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathological characteristics, survival outcomes, and genetic alterations of younger patients with gastric cancer: Results from the China National cancer Center and cBioPortal datasets.
Niu P; Huang H; Zhao L; Wang T; Zhang X; Wang W; Zhang Y; Guo C; Zhao D; Chen Y
Cancer Med; 2022 Aug; 11(16):3057-3073. PubMed ID: 35486034
[TBL] [Abstract] [Full Text] [Related]
9. Correlation between
Hu S; Zhao X; Qian F; Jin C; Hou K
Comput Math Methods Med; 2021; 2021():1522250. PubMed ID: 34603481
[TBL] [Abstract] [Full Text] [Related]
10. FGFR2 alteration as a potential therapeutic target in poorly cohesive gastric carcinoma.
Wang Y; Shi T; Wang X; Hu J; Yu L; Liu Q; Wu N; Liu B; Wei J
J Transl Med; 2021 Sep; 19(1):401. PubMed ID: 34551773
[TBL] [Abstract] [Full Text] [Related]
11. Screening and clinical significance of lymph node metastasis-related genes within esophagogastric junction adenocarcinoma.
Han R; Chen G; Li M; Peng ZM; Xu L
Cancer Med; 2021 Aug; 10(15):5088-5100. PubMed ID: 34152098
[TBL] [Abstract] [Full Text] [Related]
12. Molecular characterization of ctDNA from Chinese patients with advanced gastric adenocarcinoma reveals actionable alterations for targeted and immune therapy.
Zhang M; Qi C; Wang Z; Chen H; Zhao X; Zhang X; Zhou Y; Gao C; Bai Y; Jia S; Ji J
J Mol Med (Berl); 2021 Sep; 99(9):1311-1321. PubMed ID: 34057552
[TBL] [Abstract] [Full Text] [Related]
13. Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer.
Zhang L; Wang Y; Li Z; Lin D; Liu Y; Zhou L; Wang D; Wu A; Li Z
Diagn Pathol; 2021 May; 16(1):38. PubMed ID: 33933102
[TBL] [Abstract] [Full Text] [Related]
14. Clonal Architectures Predict Clinical Outcome in gastric Adenocarcinoma Based on Genomic Variation, Tumor Evolution, and Heterogeneity.
Ren C; Wu C; Wang N; Lian C; Yang C
Cell Transplant; 2021; 30():963689721989606. PubMed ID: 33900127
[TBL] [Abstract] [Full Text] [Related]
15. Identification of PIK3CA multigene mutation patterns associated with superior prognosis in stomach cancer.
Yu Y; Xie Z; Zhao M; Lian X
BMC Cancer; 2021 Apr; 21(1):368. PubMed ID: 33827485
[TBL] [Abstract] [Full Text] [Related]
16. Deep Targeted Sequencing and Its Potential Implication for cancer Therapy in Chinese Patients with gastric Adenocarcinoma.
Yu P; Wang Y; Yu Y; Wang A; Huang L; Zhang Y; Liu W; Wu H; Yao M; Du YA; Cheng X
Oncologist; 2021 May; 26(5):e756-e768. PubMed ID: 33511732
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic significance of LDL receptor-related protein 1B in patients with gastric cancer.
Yasufuku I; Saigo C; Kito Y; Yoshida K; Takeuchi T
J Mol Histol; 2021 Apr; 52(2):165-172. PubMed ID: 33389427
[TBL] [Abstract] [Full Text] [Related]
18. Integrated genetic and epigenetic analysis of cancer-related genes in non-ampullary duodenal adenomas and intramucosal adenocarcinomas.
Ota R; Sawada T; Tsuyama S; Sasaki Y; Suzuki H; Kaizaki Y; Hasatani K; Yamamoto E; Nakanishi H; Inagaki S; Tsuji S; Yoshida N; Doyama H; Minato H; Nakamura K; Kasashima S; Kubota E; Kataoka H; Tokino T; Yao T; Minamoto T
J Pathol; 2020 Nov; 252(3):330-342. PubMed ID: 32770675
[TBL] [Abstract] [Full Text] [Related]
19. Integrated characterisation of cancer genes identifies key molecular biomarkers in stomach adenocarcinoma.
Wang H; Shen L; Li Y; Lv J
J Clin Pathol; 2020 Sep; 73(9):579-586. PubMed ID: 32034058
[TBL] [Abstract] [Full Text] [Related]
20. Neoantigens Derived from Recurrently Mutated Genes as Potential Immunotherapy Targets for gastric cancer.
Zhou J; Zhao W; Wu J; Lu J; Ding Y; Wu S; Wang H; Ding D; Mo F; Zhou Z; Teng L; Chen S
Biomed Res Int; 2019; 2019():8103142. PubMed ID: 31312661
[TBL] [Abstract] [Full Text] [Related]
[Next]
